Fig. 3

Effect of HGF treatment on the migration of human myogenic precursors (CHQ) towards ECM proteins. Hundred thousand human CHQ myoblasts were allowed to migrate across Transwell chambers, whose inserts were previously coated with BSA, laminin-111 (LN), or fibronectin (FN) plus HGF (10-100 ng/ml). The presence of HGF significantly enhanced the cell migration driven by LN and FN. Each bar represents the mean ± SE of four independent experiments. *p < 0.05 versus BSA; ***p < 0.001 versus BSA; ### p < 0.001 versus LN; £££ p < 0.001 versus FN